The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

被引:8
|
作者
Rakotoarivelo, Volatiana [1 ,2 ]
Mayer, Thomas Z. [1 ,2 ,3 ,4 ]
Simard, Melissa [1 ,2 ]
Flamand, Nicolas [1 ,2 ]
Di Marzo, Vincenzo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Laval, Ctr Rech Inst, Dept Med, Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada
[2] Univ Laval, Canada Excellence Res Chair Microbiome Endocannabi, Quebec City, PQ G1V 0V6, Canada
[3] Univ Laval, Ecole Nutr, Inst Nutr & Aliments Fonct, Quebec City, PQ G1V 0V6, Canada
[4] Univ Laval, Ecole Nutr, Ctr NUTRISS, Quebec City, PQ G1V 0V6, Canada
[5] Joint Int Unit CNR Italy & Univ Laval, Chem & Biomol Res Microbiome & Its Impact Metab H, Quebec City, PQ G1V 0V6, Canada
来源
MOLECULES | 2024年 / 29卷 / 14期
基金
加拿大健康研究院;
关键词
inflammatory diseases; inflammation; cannabinoid; endocannabinoid; cannabinoid receptor; ACID AMIDE HYDROLASE; ENDOGENOUS LIGAND 2-ARACHIDONOYLGLYCEROL; MONOGLYCERIDE LIPASE DEFICIENCY; INNATE LYMPHOID-CELLS; FATTY LIVER-DISEASE; TYPE-2; RECEPTOR; MURINE MODEL; ENDOCANNABINOID SYSTEM; EXPERIMENTAL COLITIS; NOLADIN ETHER;
D O I
10.3390/molecules29143381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of inflammatory diseases is a heavy burden on modern societies. Cannabis has been used for several millennia to treat inflammatory disorders such as rheumatism or gout. Since the characterization of cannabinoid receptors, CB1 and CB2, the potential of cannabinoid pharmacotherapy in inflammatory conditions has received great interest. Several studies have identified the importance of these receptors in immune cell migration and in the production of inflammatory mediators. As the presence of the CB2 receptor was documented to be more predominant in immune cells, several pharmacological agonists and antagonists have been designed to treat inflammation. To better define the potential of the CB2 receptor, three online databases, PubMed, Google Scholar and clinicaltrial.gov, were searched without language restriction. The full texts of articles presenting data on the endocannabinoid system, the CB2 receptor and its role in modulating inflammation in vitro, in animal models and in the context of clinical trials were reviewed. Finally, we discuss the clinical potential of the latest cannabinoid-based therapies in inflammatory diseases.
引用
收藏
页数:36
相关论文
共 50 条
  • [31] Peripheral cannabinoid receptor, CB2, regulates bone mass
    Ofek, O
    Karsak, M
    Leclerc, N
    Fogel, M
    Frenkel, B
    Wright, K
    Tam, J
    Attar-Namdar, M
    Kram, V
    Shohami, E
    Mechoulam, R
    Zimmer, A
    Bab, I
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (03) : 696 - 701
  • [32] Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands
    Yang, Jing-Fang
    Williams, Alexander H.
    Penthala, Narsimha R.
    Prather, Paul L.
    Crooks, Peter A.
    Zhan, Chang-Guo
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (20): : 3455 - 3463
  • [33] Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
    Ndong, Christian
    O'Donnell, Dajan
    Ahmad, Sultan
    Groblewski, Thierry
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 669 (1-3) : 24 - 31
  • [34] Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
    Alapafuja, Shakiru O.
    Nikas, Spyros P.
    Ho, Thanh C.
    Tong, Fei
    Benchama, Othman
    Makriyannis, Alexandros
    MOLECULES, 2019, 24 (19):
  • [35] Distribution of CB2 Cannabinoid Receptor in Adult Rat Retina
    Lopez, Ester M.
    Tagliaferro, Patricia
    Onaivi, Emmanuel S.
    Lopez-Costa, Juan J.
    SYNAPSE, 2011, 65 (05) : 388 - 392
  • [36] The CB2 cannabinoid receptor controls myeloid progenitor trafficking
    Palazuelos, Javier
    Davoust, Nathalie
    Julien, Boris
    Hatterer, Eric
    Aguado, Tania
    Mechoulam, Raphael
    Benito, Cristina
    Romero, Julian
    Silva, Augusto
    Guzman, Manuel
    Nataf, Serge
    Galve-Roperh, Ismael
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) : 13320 - 13329
  • [37] CANNABINOID RECEPTOR CB2 AND IMMUNE MODULATION OF HEPATIC FIBROSIS
    Avraham, Yosefa
    Doron, Sarit
    Mahmud, Mahamid N.
    Berry, Elliot M.
    Safadi, Rifaat
    HEPATOLOGY, 2008, 48 (04) : 911A - 911A
  • [38] Cloning and molecular characterization of the rat CB2 cannabinoid receptor
    Brown, SM
    Wager-Miller, J
    Mackie, K
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1576 (03): : 255 - 264
  • [39] Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands
    Worm, Karin
    Zhou, Q. Jean
    Saeui, Christopher T.
    Green, Rosalyn C.
    Cassel, Joel A.
    Stabley, Gabriel J.
    DeHaven, Robert N.
    Conway-James, Nathalie
    LaBuda, Christopher J.
    Koblish, Michael
    Little, Patrick J.
    Dolle, Roland E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2830 - 2835
  • [40] Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol
    Ortega-Alvaro, Antonio
    Ternianov, Alexander
    Aracil-Fernandez, Auxiliadora
    Navarrete, Francisco
    Salud Garcia-Gutierrez, Maria
    Manzanares, Jorge
    ADDICTION BIOLOGY, 2015, 20 (01) : 43 - 55